Figure 1 | Scientific Reports

Figure 1

From: Estimating ranibizumab injection numbers and visual acuity at 12 months based on 2-month data on branch retinal vein occlusion treatment

Figure 1

(a) Number of ranibizumab injections per year (SE) according to the number of injections administered up to the end of Month 2 (safety analysis set). (b) Corresponding mean (SE) visual acuity (letters) at Month 12. p values obtained from t-test with Tukey’s method. By analysis of variance, for 1 vs 2 vs 3 injections, p < 0.01. In (b), the colored bars represent the BCVA at baseline and the gray bar represents the BCVA at Month 12. BCVA best corrected visual acuity, RBZ ranibizumab, SE standard error.

Back to article page